Table 2. TMT proteomics on wild-type and fap57 mutants.
| Protein/Gene | No. Peptides | Fold change relative to all samples | ||
|---|---|---|---|---|
| Average of wild-typea | fap57-1b | fap57-2b | ||
| FAP57 Cre04.g217917 |
107 | 1.0 | 0.1/0.1 | 0.1/0 |
| DHC7; g Cre06.g265950 |
341 | 0.98 | 0.5/0.5 | 0.6/0.5 |
| DHC3; minor g Cre06.g265950 |
78 | 0.95 | 0.5/0.5 | 0.5/0.6 |
| DHC2; d Cre09.g392282 |
540 | 1.0 | 0.8/0.8 | 0.8/0.8 |
| Translational elongation factor 1α Cre06.g263450 |
220 | 0.98 | 0.3/0.6 | 0.6/0.6 |
| Cre12.g540050 | 5 | 1.05 | 0.3/0.3 | 0.3/0.3 |
| Fbox/WD repeat Cre13.g562800 |
5 | 1.0 | 0.3/0.3 | 0.3/0.3 |
| CCDC89 Cre03.g174800 |
4 | 0.92 | 0.6/0.7 | 0.5/0.6 |
| FAP264 Cre10.g438500 |
3 | 0.9 | 0.3/0.3 | 0.3/0.2 |
| FBB7 Cre03.g143827 |
27 | 0.95 | 2.0/2.0 | 2.0/1.3 |
a the average of two axonemal preparations from CC-125 and two axonemal preparations from CC-4533.
b the ratio for each of mutant strain to the wild-type strains is presented